PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30001502-0	2018	Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen-progestin.	Valproic Acid	58-71	adenosine deaminase	Rattus norvegicus	14-33	
30001502-2	2018	We hypothesized that disruption of glucoregulation and liver triglyceride (TG) accumulation induced by COC use would be abated by valproic acid (VPA) treatment through suppression of adenosine deaminase (ADA) and xanthine oxidase (XO) activities.	Valproic Acid	130-143	adenosine deaminase	Rattus norvegicus	183-202	
30001502-2	2018	We hypothesized that disruption of glucoregulation and liver triglyceride (TG) accumulation induced by COC use would be abated by valproic acid (VPA) treatment through suppression of adenosine deaminase (ADA) and xanthine oxidase (XO) activities.	Valproic Acid	130-143	adenosine deaminase	Rattus norvegicus	204-207	
30001502-2	2018	We hypothesized that disruption of glucoregulation and liver triglyceride (TG) accumulation induced by COC use would be abated by valproic acid (VPA) treatment through suppression of adenosine deaminase (ADA) and xanthine oxidase (XO) activities.	Valproic Acid	145-148	adenosine deaminase	Rattus norvegicus	183-202	
30001502-2	2018	We hypothesized that disruption of glucoregulation and liver triglyceride (TG) accumulation induced by COC use would be abated by valproic acid (VPA) treatment through suppression of adenosine deaminase (ADA) and xanthine oxidase (XO) activities.	Valproic Acid	145-148	adenosine deaminase	Rattus norvegicus	204-207